Cerebral Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The cerebral palsy pipeline market research report provides comprehensive information on the therapeutics under development for Cerebral Palsy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cerebral Palsy and features dormant and discontinued projects.
What are the key targets in the cerebral palsy pipeline market?
The key targets in the cerebral palsy pipeline market are Botulinum Neurotoxin Type A, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Muscarinic Acetylcholine Receptor M1, Nitric Oxide Synthase Brain, and Synaptosomal Associated Protein 25.
What are the key MoA in the cerebral palsy pipeline market?
The key MoA in the cerebral palsy pipeline market are Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Muscarinic Acetylcholine Receptor M1 Antagonist, Nitric Oxide Synthase Brain Inhibitor, and Synaptosomal Associated Protein 25 Inhibitor.
What are the key RoA in the cerebral palsy pipeline market?
The key RoA in the cerebral palsy pipeline market are Intravenous, Parenteral, Intrathecal, Oral, Intradermal, Intramuscular, and Subcutaneous. Intravenous has the highest number of pipeline products in the cerebral palsy pipeline market.
Cerebral palsy pipeline market, by RoA
For more RoA insights, download a free report sample
What are the key molecule type in the cerebral palsy pipeline market?
The key molecule type in the cerebral palsy pipeline market are Cell Therapy, Small Molecule, Protein, and Recombinant Protein. Cell Therapy has the highest number of pipeline products in the cerebral palsy pipeline market.
Cerebral palsy pipeline market, by molecule type
For more molecule type insights, download a free report sample
What are the key companies in the cerebral palsy pipeline market?
The key companies in the cerebral palsy pipeline market are Hope Biosciences LLC, Baylx Inc, BrainRepair UG, Cell Tech Pharmed Co, CytoDel Inc, FamiCord Group, Help Therapeutics, Hopstem Biotechnology LLC, iCELL Biotechnology Co Ltd, and Kashiv BioSciences LLC.
Cerebral palsy pipeline market, by companies
To know more about companies, download a free report sample
Marker report overview
Key targets | Botulinum Neurotoxin Type A, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Muscarinic Acetylcholine Receptor M1, Nitric Oxide Synthase Brain, and Synaptosomal Associated Protein 25 |
Key MoA | Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Muscarinic Acetylcholine Receptor M1 Antagonist, Nitric Oxide Synthase Brain Inhibitor, and Synaptosomal Associated Protein 25 Inhibitor |
Key RoA | Intravenous, Parenteral, Intrathecal, Oral, Intradermal, Intramuscular, and Subcutaneous |
Key Molecule type | Cell Therapy, Small Molecule, Protein, and Recombinant Protein |
Key companies | Hope Biosciences LLC, Baylx Inc, BrainRepair UG, Cell Tech Pharmed Co, CytoDel Inc, FamiCord Group, Help Therapeutics, Hopstem Biotechnology LLC, iCELL Biotechnology Co Ltd, and Kashiv BioSciences LLC |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Cerebral Palsy (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Cerebral Palsy (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Cerebral Palsy (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Cerebral Palsy (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Cerebral Palsy (Central Nervous System)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Cerebral Palsy (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Cerebral Palsy (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
BrainRepair UG
Cell Tech Pharmed Co
CytoDel Inc
FamiCord Group
Help Therapeutics
Hope Biosciences LLC
Hopstem Biotechnology LLC
iCELL Biotechnology Co Ltd
Kashiv BioSciences LLC
Kidswell Bio Corp
Meridigen Biotech Co Ltd
MGC Pharmaceuticals Ltd
Revance Therapeutics Inc
Rohto Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the cerebral palsy pipeline market?
The key targets in the cerebral palsy pipeline market are Botulinum Neurotoxin Type A, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Muscarinic Acetylcholine Receptor M1, Nitric Oxide Synthase Brain, and Synaptosomal Associated Protein 25.
-
What are the key MoA in the cerebral palsy pipeline market?
The key MoA in the cerebral palsy pipeline market are Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Muscarinic Acetylcholine Receptor M1 Antagonist, Nitric Oxide Synthase Brain Inhibitor, and Synaptosomal Associated Protein 25 Inhibitor.
-
What are the key RoA in the cerebral palsy pipeline market?
The key RoA in the cerebral palsy pipeline market are Intravenous, Parenteral, Intrathecal, Oral, Intradermal, Intramuscular, and Subcutaneous.
-
What are the key molecule type in the cerebral palsy pipeline market?
The key molecule type in the cerebral palsy pipeline market are Cell Therapy, Small Molecule, Protein, and Recombinant Protein.
-
What are the key companies in the cerebral palsy pipeline market?
The key companies in the cerebral palsy pipeline market are Hope Biosciences LLC, Baylx Inc, BrainRepair UG, Cell Tech Pharmed Co, CytoDel Inc, FamiCord Group, Help Therapeutics, Hopstem Biotechnology LLC, iCELL Biotechnology Co Ltd, and Kashiv BioSciences LLC.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.